Phase I to II Multicenter Study of Oblimersen Sodium, a Bcl-2 Antisense Oligonucleotide, in Patients With Advanced Chronic Lymphocytic Leukemia
Year: 2005
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Authors: Susan M. O'Brien, Charles C. Cunningham, Anatoliy K. Golenkov, Anna G. Turkina, Steven C. Novick, Kanti R. Rai
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1963571549
